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Background
Contact sensitizers induce an innate immune response in
dendritic cells (DC) enhancing antigen presentation and
T cell response. Little is known concerning the effect of
systemic drugs causing T-cell mediated cutaneous
adverse drug reactions (CARDs). Therefore, we studied
the in vitro effect of drugs on THP-1 cells, a monocyte
cell line widely used to show activation by contact
sensitizers.
Methods
THP-1 cells were stimulated for 24h with allopurinol
(ALP), oxypurinol (OXP), ampicillin (AMP), amoxicillin
(AMX), carbamazepine, sodium valproate (VAP), lipopo-
lysaccharide (LPS), a DC maturation stimulus, and the
strong contact sensitizer, 1-fluoro-2,4-dinitrobenzene
(DNFB), at concentrations that reduced cell viability to
70%, evaluated by the Alamar Blue test. We studied p38
MAPK activation by Western Blot and the expression of
DC maturation markers, pro-inflammatory cytokine/
chemokines and heme oxygenase 1 (HMOX-1) genes by
real-time RT-PCR.
Results
All drugs significantly upregulated HMOX-1 gene (mean
log2 values varying from 1.842 ± 0.164, p<0.01 for AMP to
3.096 ± 0.575, p<0.05 for OXP). All drugs, but the anti-
epileptics, increased the pro-inflammatory chemokine
IL-8/CXCL8 (mean log2 values varying from 0.959 ±
0.154, p<0.05 for AMX and 4.729 ± 0.508, p<0.05 for
OXP). Both DC maturations makers (CD83 and CD40)
were significantly upregulated by VAP and AMP
(respectively 1.594±0.672, p<0.05 and 0.999±0.226, p<0.05)
and CD83 was also upregulated by VAP. Other genes stu-
died were irregularly activated. Moreover, like DNFB, all
drugs activated p38 MAPK. In general, allopurinol and
oxypurinol showed the most intense effect, very similar to
DNFB and inferior to LPS. The concomitant stimulation
of THP-1 cells by OXP and AMP had no additive effect
on the endpoints studied.
Discussion
Like contact sensitizers, systemic drugs activate THP-1
cells in vitro. Direct activation of monocytic or DC that
participate in antigen presentation may be an important
step in the pathophysiology of delayed immune mediated
CADRs. Drugs use different signalling pathways and affect
these cells with a different intensity that may reflect the
frequency and severity of the CADRs they cause. The
effect of systemic drugs on THP-1 cells needs to be further
studied in order to confirm the usefulness of this in vitro
test to study their sensitizing potential, similarly to its use
for contact sensitizers.
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